Trademarks = 4

Forward Citations = 25

Loading Chart...

6 inventors (with patents filed for the assignee):

Xingxiang Li (2 out of 3 patents)

Tianxin Wang (2 out of 10 patents)

Xing-Xiang Li (2 out of 2 patents)

4. Junichi Masuyama (1 out of 2 patents)

5. Sanehiko Fujita (1 out of 1 patent)

6. Jun-ichi Masuyama (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. D939105 - Testing cassette (2021-12-21),

2. 10041105 - Methods and devices for detection of resistance to an enzyme inhibitor (2018-08-07),

3. 9339537 - Cancer inhibiting agent, antibody production enhancing agent, and therapeutic agent for hepatitis (2016-05-17),

4. 8613916 - Immunotherapy for pancreatic cancer (2013-12-24),

5. 8558004 - Reagents and kits for detection of influenza virus and the like (2013-10-15),

6. 7893272 - Reagents and kits for detection of influenza virus and the like (2011-02-22),

Company Overview

Cellex Corporation is a biotechnology company specializing in developing innovative cell culture technologies for the biopharmaceutical industry. Their proprietary bioreactor systems enable efficient and scalable production of high-quality cells for use in drug discovery and development. With a focus on improving cell culture processes, Cellex provides cutting-edge solutions to meet the growing demands of the biotech market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#2,469 in Tokyo

#5,990 in Japan

Tokyo, Japan

Cellex Corporation

Forward Citations = 25

6 inventors:

Xingxiang Li (2 out of 3 patents)

Tianxin Wang (2 out of 10 patents)

Xing-Xiang Li (2 out of 2 patents)

4. Junichi Masuyama (1 out of 2 patents)

5. Sanehiko Fujita (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellex Corporation. Retrieved from https://idiyas.com/company/cellex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]